
Harm Reduction Hacks is a comprehensive microsite and resource to guide organizations developing new and/or existing syringe services programs in program design, implementation, and organizational sustainability.
Harm Reduction Hacks is a comprehensive microsite and resource to guide organizations developing new and/or existing syringe services programs in program design, implementation, and organizational sustainability.
Harm reduction strategies and tools should be accessible to everyone – regardless of location, time, and/or experience.
Language is foundational to how we understand and interact with ourselves and others. Unclear language can lead to confusion and inefficiencies, while stigmatizing and prejudicial language leads to harmful practices and dehumanizes people.
Building on last month’s episode about providing HIV and substance use care for people who are incarcerated, this month the Boston Medical Center Team talks with Dr.
This publication describes the recent trends of drug overdose deaths in the United States (U.S.) and the benefits of adopting harm reduction approaches.
Navigating the HIV and substance use systems of care presents a number of unique challenges, many of which can become more complex depending on a person’s housing, employment, mental health, or economic situation.
This CDC report provides updated data related to HIV prevalence among people who inject drugs, documenting findings that underscore the need for low-barrier access to comprehensive and integrated needs-based syringe service programs for necessary prevention and
This PowerPoint slide deck reviews the foundations of harm reduction philosophy and practice, summarizes drug user health issues and trends, and aims to increase cultural competence and humility when working with people who use drugs.
This newly released national strategy confronts the rising rates of opioid and non-opioid related fatal overdoses.
In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.